Gold–Silver Alloy Nanoparticle-Incorporated Pitaya-Type Silica Nanohybrids for Sensitive Competitive Lateral Flow Immunoassay
Analytical Chemistry · 28.11.2023 · 95 (47) · 17318-17327
DOI: 10.1021/acs.analchem.3c03569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 15.11.2023. Verfasst von Lu Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. China. Hauptthemen laut MEDLINE: Silicon Dioxide, Metal Nanoparticles. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. China.
ORCID-Profile: Liang Huang, Jing Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Tong, L., Li, D., Huang, M., Huang, L., & Wang, J. (2023). Gold–Silver Alloy Nanoparticle-Incorporated Pitaya-Type Silica Nanohybrids for Sensitive Competitive Lateral Flow Immunoassay. Analytical Chemistry, 95(47), 17318-17327. https://doi.org/10.1021/acs.analchem.3c03569
Vancouver
Tong L, Li D, Huang M, Huang L, Wang J. Gold–Silver Alloy Nanoparticle-Incorporated Pitaya-Type Silica Nanohybrids for Sensitive Competitive Lateral Flow Immunoassay. Analytical Chemistry. 2023;95(47):17318-17327. doi:10.1021/acs.analchem.3c03569
BibTeX
@article{Tong2023,
author = {Tong, Lu and Li, Daquan and Huang, Mei and Huang, Liang and Wang, Jing},
title = {Gold–Silver Alloy Nanoparticle-Incorporated Pitaya-Type Silica Nanohybrids for Sensitive Competitive Lateral Flow Immunoassay},
journal = {Analytical Chemistry},
year = {2023},
volume = {95},
number = {47},
pages = {17318--17327},
doi = {10.1021/acs.analchem.3c03569}
}
EUVIMED